|
12.12.2016 |
EN |
Official Journal of the European Union |
C 462/24 |
Order of the General Court of 18 October 2016 — Laboratoire de la mer v EUIPO — Boehringer Ingelheim Pharma (RESPIMER)
(Case T-109/16) (1)
((EU trade mark - Opposition proceedings - Application for EU word mark RESPIMER - Earlier EU word mark RESPIMAT - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 - Action manifestly lacking any foundation in law))
(2016/C 462/31)
Language of the case: English
Parties
Applicant: Laboratoire de la mer (Saint-Malo, France) (represented by: S. Szilvasi, lawyer)
Defendant: European Union Intellectual Property Office (represented by: D. Hanf, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO: Boehringer Ingelheim Pharma GmbH & Co. KG (Ingelheim, Germany)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 21 January 2016 (Case R 3109/2014-5), relating to opposition proceedings between Boehringer Ingelheim Pharma and Laboratoire de la mer.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Laboratoire de la mer to pay the costs. |